Images List Premium Download Classic

Diabetes

Diabetes-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Telemonitoring system !
Esvyda!, Inc.
August 17, 2017 - N°20170235909

Disclosed is a telemonitoring system and associated methods. A doctor creates a care plan for a patient with a chronic condition, such as diabetes. The care plan includes a medication plan, an exercise plan, a healthy eating plan, etc., and the care plan is input at a telemonitoring system. When the patient returns home, the telemonitoring system helps the patient ...
Protein and protein conjugate for diabetes treatment, and applications thereof
Adda Biotech Inc.
August 17, 2017 - N°20170233447

The present invention relates to the field of biopharmaceuticals, and in particular to a protein, a protein conjugate, a pharmaceutical composition and its use for treating diabetes. The fusion protein of the present invention is obtained by linking two polypeptides, wherein one polypeptide is an interleukin-1 receptor antagonistic protein or an analogue thereof, and another polypeptide is glp-1 receptor binding ...
Cyclic polypeptides for the treatment of heart failure
Adda Biotech Inc.
August 17, 2017 - N°20170233443

Or an amide, an ester or a salt thereof, or a bioconjugate thereof, wherein x1, x3, x4, x7, x8, x9, x10, x11, x12 and x13 are defined herein. The polypeptides are agonist of the apj receptor. The invention also relates to a method for manufacturing the polypeptides of the invention or bioconjugates thereof, and their therapeutic uses such as treatment ...
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Soluble mediator
The Walter And Eliza Hall Institute Of Medical Research
August 17, 2017 - N°20170232061

The present disclosure relates to a soluble cd52 glycoprotein and its use in treating diseases regulated by effector t-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of cd52, and to diagnostic methods based on the detection of cd52 expression levels in a ...
Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for ...
Strongbridge Biopharma Plc
August 17, 2017 - N°20170232056

The present invention provides compositions comprising water soluble peptides with poor solubility in isotonic solutions which exhibit enhanced bioavailability with reduced adverse effects including injection site reactions. Methods are also disclosed for using such compositions for the treatment of diseases including, but not limited to, cancer, type 2 diabetes, acromegaly, metabolic disorders, endocrine disorders, exocrine tumors, and hormone-related tumors. Methods to ...
Drug combinations and methods to stimulate embryonic-like regeneration to treat diabetes and other diseases
University Of Southern California
August 17, 2017 - N°20170232053

Stem cell-based therapies can potentially reverse organ dysfunction and diseases but the removal of impaired tissue and reactivation of the program leading to organ regeneration pose major challenges. In mice, a four-day fasting mimicking diet (fmd) induces a step-wise expression of sox17 and pdx-1, resembling that observed during pancreatic development and followed by ngn3-driven generation of insulin-producing β...
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method for treating a neurovascular complication of diabetes mellitus
King Saud University
August 17, 2017 - N°20170231925

A method of preventing and/or treating a disease caused by diabetes complications includes administering to a patient in need thereof, an effective amount of thymoquinone or a pharmaceutically acceptable salt thereof, either singly or in combination with a pharmaceutically acceptable carrier, diluent or excipient. The disease can be at least one of retinopathy, nephropathy, neuropathy, and neurological disorder.
Apparatus, system and method for chronic disease monitoring
Resmed Sensor Technologies Limited
August 17, 2017 - N°20170231504

An apparatus, system, and method for monitoring a person suffering from a chronic medical condition predicts and assesses physiological changes which could affect the care of that subject. Examples of such chronic diseases include (but are not limited to) heart failure, chronic obstructive pulmonary disease, asthma, and diabetes. Monitoring includes measurements of respiratory movements, which can then be analyzed for ...
Pig model for diabetes
Aarhus Universitet
August 17, 2017 - N°20170231204

The present invention relates to a transgenic pig comprising a mutated iapp gene and displaying a phenotype associated with diabetes. The invention also relates to a transgenic blastocyst, embryo, fetus, donor cell and/or cell nucleusderived from said transgenic pig. The invention further relates to use of the transgenic pig as a model system for studying therapy, treatment and/or ...
Electronic phenotyping technique for diagnosing chronic kidney disease
Icahn School Of Medicine At Mount Sinai
August 10, 2017 - N°20170228506

An example method of diagnosing chronic kidney disease (ckd) includes obtaining an electronic medical record for a patient having medical data. The medical data includes an indication if the patient had been previously diagnosed with ckd, an indication if the patient had previously undergone a kidney transplant, an indication if the patient had previously undergone a renal dialysis procedure, an ...
Insulinotropic peptide derivative with modified n-terminal charge
Hanmi Pharm. Co., Ltd.
August 10, 2017 - N°20170226175

The present invention relates to an insulinotropic peptide derivative with a modified n-terminal charge and a pharmaceutical composition including the same. Specifically, the insulinotropic peptide derivative is characterized in that the n-terminal positive charge of the insulinotropic peptide is modified to a neutral or net negative charge at neutral ph. The insulinotropic peptide derivative according to the present invention is ...
Chemical compounds and use thereof for improving muscular quality
Universite Paris 6 Pierre Et Marie Curie
August 10, 2017 - N°20170226151

Chemical compounds and the therapeutic use thereof, in particular for improving muscular quality in mammals. More particularly, a method of improving muscular quality in sarcopenic mammals and treating and/or preventing sarcopenia using the chemical compounds and, in particular, sarcopenic obesity and the associated complications and/or pathologies thereof, such as loss of strength, muscle mass, performance and of physical ...
N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase
Universiteit Leiden
August 10, 2017 - N°20170226058

Deoxynojirimycin and deoxygalactonojirimycin derivatives according to the present invention are n-alkylated d-galacto, d-gluco- or l-ido-deoxynojirimycin with a linear methyloxypentyl group bearing various sidegroups and a non-fused bicyclic aromatic group (“x”) on the methyloxy-carbon. These compounds display an increased inhibitory potency towards gcs, and/or an increased inhibitory potency towards gba2, and/or a decreased inhibitory potency ...
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method of preventing and treating retinal microvasculature inflammation using c-met signaling pathway inhibition
Valtronic Technologies (holding) Sa
August 10, 2017 - N°20170224815

The present invention provides methods for preventing retinal microvasculature inflammation in patients with diabetes who are highly susceptible to developing diabetic retinopathy and/or diabetic macular edema. The methods comprise inhibiting c-met signaling pathway by administering a c-met inhibitor alone or in combination with anti-vegf or steroid medications to diabetic patients. The methods thus provide a surprisingly effective prophylaxis and/...
Nutritional support method for health issues
Cortcontrol
August 10, 2017 - N°20170224746

A method of improving the outcome or recovery for depression, diabetes, cardiovascular disease, alzheimers progression, or breast cancer. This method consists of administering a food which includes transfer factor, lactic acid generating bacteria, and/or glucans in appropriate combinations and dosage levels. The food reduces cortisol levels, enhances the immune system, and balances hormones and cytokines. Dosage amounts are dependent ...
Phospholipid-containing marine extracts for treatment of cardiovascular diseases
Neptune Technologies & Bioressources, Inc.
August 10, 2017 - N°20170224742

The present invention relates to a method of treatment and/or prevention of cardiovascular disease, rheumatoid arthritis, skin cancer, premenstrual syndrome, diabetes and transdermal transport enhancement. The method comprises the administration of a therapeutically effective amount of krill and/or marine oil to a patient. The present invention also relates to a composition for the treatment and/or prevention of ...
Aromatic farnesyl compound and application thereof
Institute Of Microbiology, Chinese Academy Of Sciences
August 10, 2017 - N°20170224651

Aromatic farnesyl compound and application of a pharmaceutical salt thereof as an inhibitor of α-glucosidase, dipeptidyl peptidase-4, aldose reductase, protein tyrosine phosphatase-1b or hmg-coa reductase, or use thereof in preparing medicine and functional healthcare products having a liver protective function and/or for treating and/or preventing type ii diabetes, diabetic retinopathy, diabetic foot disease, and hyperlipidemia.
Specialized flour for nutrition meals for diabetes and preparation method and use thereof
Institute Of Microbiology, Chinese Academy Of Sciences
August 10, 2017 - N°20170224001

Disclosed are specialized flour for nutrition meals for diabetes and a preparation method and use thereof. The flour is based on cereal meal as a basic material and is added to a defatted soybean vegetable protein powder and a soybean tissue isolated dietary fiber power, wherein in the dry flour base, the content of protein is 20-26 weight %, the content ...
System and method for decision support using lifestyle factors
Dexcom, Inc.
August 03, 2017 - N°20170220751

Systems and methods are provided relating to open loop decision-making for management of diabetes. People with diabetes face many problems in controlling their glucose because of the complex interactions between food, insulin, exercise, stress, activity, and other physiological and environmental conditions. Established principles of management of glucose sometimes are not adequate because there is a significant amount of variability in ...
System and method for decision support using lifestyle factors
Dexcom, Inc.
August 03, 2017 - N°20170220750

Systems and methods are provided relating to open loop decision-making for management of diabetes. People with diabetes face many problems in controlling their glucose because of the complex interactions between food, insulin, exercise, stress, activity, and other physiological and environmental conditions. Established principles of management of glucose sometimes are not adequate because there is a significant amount of variability in ...
Composition and method of using mir-302 precursors as drugs for treating alzheimer's diseases
Mello Biotechnology, Inc.
August 03, 2017 - N°20170218362

This invention generally relates to a composition and method of using recombinant micrornas (mirna) and their hairpin-like precursors (pre-mirna) as therapeutic drugs for treating alzheimer's diseases (ad). More specifically, the present invention relates to the use of man-made mirna mir-302 precursors (pre-mir-302) for ad therapy in humans. These pre-mir-302 molecules can be mass produced in prokaryotes as a form of ...
Loading